Related by context. Frequent words. (Click for all words.) 67 nab paclitaxel 59 dose escalation trial 58 dose cohorts 58 HGS ETR1 57 IMGN# 57 randomized Phase III 57 Phase Ia 57 mcg kg 57 dose escalation 56 axitinib 56 imetelstat 56 Phase 1b 56 phase IIa 56 Phase 1b trial 56 Phase 1b clinical 56 CA4P 55 CoFactor 55 Taxotere R 55 Phase 2a trial 55 TELCYTA 55 prospective randomized controlled 55 Pharmacokinetic 55 Phase Ib 55 Phase 1a 54 Cotara 54 neoadjuvant 54 azacitidine 54 phase IIb 54 tolerated dose MTD 54 decitabine 54 PXD# 54 multicenter randomized 53 carboplatin 53 Phase 2b trial 53 safety tolerability pharmacokinetics 53 multicenter clinical 53 REOLYSIN R 53 Taxotere ® 52 REOLYSIN 52 evaluable patients 52 teduglutide 52 TORISEL 52 OXi# 52 temsirolimus 52 ThermoDox 52 docetaxel 52 Neuradiab 52 GRN#L 52 gemcitabine 52 nilotinib 52 refractory multiple myeloma 51 FavId 51 tocilizumab 51 Phase 2b study 51 dose escalation study 51 PF # [001] 51 active comparator 51 Valortim 51 Phase 2a 51 ofatumumab 51 AACR NCI EORTC 51 CYC# 51 seliciclib 51 noninferiority 51 dosing regimens 51 Bortezomib 51 multicentre 51 Preclinical studies 51 AP# [003] 51 Phase 2b clinical 51 temozolomide 51 blinded placebo controlled 51 Phase IIa clinical 50 HspE7 50 pharmacodynamic 50 Jevtana 50 bevacizumab 50 Phase 2a clinical 50 antitumor activity 50 thymalfasin 50 CYT# 50 relapsed multiple myeloma 50 rituximab 50 palifosfamide 50 placebo controlled randomized 50 bortezomib 50 multicenter randomized double 50 limiting toxicity 50 IMC A# 50 randomized Phase 50 dose regimens 50 AEOL # 50 TNFerade 50 Mylotarg 49 MGCD# [001] 49 evaluable 49 aflibercept 49 IIa clinical trial 49 Clinical Trial Results 49 picoplatin 49 ONCONASE